Yuhan Corporation
000100
Pozycja w akcjach
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Cena akcji
$63.22
Kapitalizacja rynkowa
$4.27B
Zmiana (1 dzień)
-3.12%
Zmiana (1 rok)
-23.57%
Kraj
KR
Handel Yuhan Corporation (000100)
Kategoria
Healthcare
Historia stopy dywidendy dla Yuhan Corporation (000100)
Stopa dywidendy (TTM) dla Yuhan Corporation (symbol akcji: 000100) na dzień 2024-12-31 wynosi: 0.36%
Średnia stopa dywidendy z ostatnich 5 lat: 0.51%
Średnia stopa dywidendy z ostatnich 5 lat: 0.51%
Historia stopy dywidendy dla Yuhan Corporation (000100) od 2007 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 0.71% | 73.17% |
| 2025 | 0.41% | 13.89% |
| 2024 | 0.36% | -33.33% |
| 2023 | 0.54% | -15.63% |
| 2022 | 0.64% | 8.47% |
| 2021 | 0.59% | 22.92% |
| 2020 | 0.48% | -40.74% |
| 2019 | 0.81% | -15.63% |
| 2018 | 0.96% | 2.13% |
| 2017 | 0.94% | -11.32% |
| 2016 | 1.06% | 55.88% |
| 2015 | 0.68% | -27.66% |
| 2014 | 0.94% | 32.39% |
| 2013 | 0.71% | -7.79% |
| 2012 | 0.77% | -6.10% |
| 2011 | 0.82% | 49.09% |
| 2010 | 0.55% | 3.77% |
| 2009 | 0.53% | 20.45% |
| 2008 | 0.44% | -8.33% |
| 2007 | 0.48% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
